Atogepant

📖 Atogepant: Patient Information Guide

A plain-language walkthrough of Atogepant — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

📄 Written from Atogepant’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🧰 More about Atogepant on HelloPharmacist

📊 Atogepant on the U.S. market: products, makers and brands

How Atogepant appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

4 companies list 15 Atogepant product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2021. Brand names on the directory include Qulipta; the rest are generics.

Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Atogepant is used (Medicaid data)

A general measure of how commonly Atogepant is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Atogepant is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Atogepant prescribed? Of the 1,599 medications we measure, Atogepant ranks #398 by Medicaid prescriptions — more than 75% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Atogepant, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 10 listed Atogepant NDCs with Medicaid activity.

🔍 Compare Atogepant products

A representative set of FDA-listed product records for Atogepant — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 15 of 15 products — FDA National Drug Code Directory. See every product, package size and price: browse all 15 Atogepant NDCs →

🏷️ Atogepant brand names

Atogepant is sold under one brand name in the FDA directory — Qulipta. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

🏭 Who makes Atogepant: manufacturers and labelers

4 companies list Atogepant products with the FDA. By number of product records, the largest are AbbVie Inc., Honour Lab Limited, MSN Life Sciences Private Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

🔗 Medications related to Atogepant